Marshall Wace’s Amylyx Pharmaceuticals AMLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-247,275
| Closed | -$875K | – | 2512 |
|
|
2025
Q1 | $875K | Buy |
247,275
+62,597
| +34% | +$222K | ﹤0.01% | 1741 |
|
|
2024
Q4 | $698K | Sell |
184,678
-99,308
| -35% | -$375K | ﹤0.01% | 1765 |
|
|
2024
Q3 | $920K | Buy |
+283,986
| New | +$920K | ﹤0.01% | 1553 |
|
|
2024
Q1 | – | Sell |
-985,114
| Closed | -$14.5M | – | 2094 |
|
|
2023
Q4 | $14.5M | Sell |
985,114
-212,646
| -18% | -$3.13M | 0.02% | 489 |
|
|
2023
Q3 | $21.9M | Sell |
1,197,760
-782,420
| -40% | -$14.3M | 0.04% | 374 |
|
|
2023
Q2 | $42.7M | Buy |
1,980,180
+840,940
| +74% | +$18.1M | 0.08% | 237 |
|
|
2023
Q1 | $33.4M | Buy |
+1,139,240
| New | +$33.4M | 0.07% | 266 |
|
|
2022
Q4 | – | Sell |
-341,064
| Closed | -$9.6M | – | 2301 |
|
|
2022
Q3 | $9.6M | Sell |
341,064
-317,309
| -48% | -$8.93M | 0.02% | 818 |
|
|
2022
Q2 | $12.7M | Buy |
658,373
+73,909
| +13% | +$1.42M | 0.03% | 643 |
|
|
2022
Q1 | $7.51M | Buy |
+584,464
| New | +$7.51M | 0.01% | 1003 |
|